Jim Simons’s Royalty Pharma RPRX Stock Holding History

Jim Simons’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$37.9M	Buy	+790,937	New	+$34.6M	0.06%	409
2024 Q2	–	Sell	-10,190	Closed	-$309K	–	3893
2024 Q1	$309K	Buy	+10,190	New	+$300K	﹤0.01%	3080
2023 Q4	–	Sell	-483,200	Closed	-$13.1M	–	4066
2023 Q3	$13.1M	Sell	483,200 -287,500	-37%	-$8.54M	0.02%	766
2023 Q2	$23.7M	Sell	770,700 -530,200	-41%	-$18M	0.03%	599
2023 Q1	$46.9M	Buy	1,300,900 +431,900	+50%	+$16M	0.06%	369
2022 Q4	$34.3M	Buy	+869,000	New	+$36.3M	0.05%	470
2022 Q2	–	Sell	-183,900	Closed	-$7.17M	–	4517
2022 Q1	$7.17M	Sell	183,900 -615,200	-77%	-$24.2M	0.01%	1348
2021 Q4	$31.8M	Buy	799,100 +15,500	+2%	+$602K	0.04%	484
2021 Q3	$28.3M	Sell	783,600 -45,000	-5%	-$1.75M	0.04%	521
2021 Q2	$34M	Buy	+828,600	New	+$35.2M	0.04%	487

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Jim Simons's RPRX Position: Q1 2026 in Review

Jim Simons opened a new position in Royalty Pharma (RPRX) in Q1 2026: 790,937 shares worth $37.9M. The stake represents 0.06% of the portfolio and ranks #409 among its holdings. This is a return to the name: Jim Simons previously reported a position in RPRX as recently as Q1 2024.

Jim Simons first reported a position in RPRX in Q2 2021 and has held it in 10 quarters since. The position peaked at $46.9M in Q1 2023. 590 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

Jim Simons held 790,937 shares of Royalty Pharma worth $37.9M as of Q1 2026.
Royalty Pharma was a new Jim Simons position in Q1 2026.
Royalty Pharma made up 0.06% of Jim Simons's portfolio in Q1 2026, its #409 holding.
Jim Simons first reported a position in Royalty Pharma in Q2 2021 and has held it in 10 quarters since.
Jim Simons's Royalty Pharma position peaked at $46.9M in Q1 2023.
590 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.